Cipla Files Fresh Bid To Revoke Bayer's Xarelto Patent
IP Law 360
JANUARY 31, 2023
An Indian pharmaceutical company has asked a London court to invalidate a Bayer Global AG patent that protects the blockbuster blood-thinner Xarelto, marking the latest attempt to nix the patent protecting the key ingredient of the drug.
Let's personalize your content